<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Immunity</journal-id>
      <journal-title-group>
        <journal-title>Immunity</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1074-7613</issn>
      <issn pub-type="epub">1097-4180</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2914224</article-id>
      <article-id pub-id-type="pmid">20637660</article-id>
      <article-id pub-id-type="publisher-id">IMMUNI1928</article-id>
      <article-id pub-id-type="doi">10.1016/j.immuni.2010.07.001</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Nonconventional Initiation Complex Assembly by STAT and NF-κB Transcription Factors Regulates Nitric Oxide Synthase Expression</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Farlik</surname>
            <given-names>Matthias</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reutterer</surname>
            <given-names>Benjamin</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schindler</surname>
            <given-names>Christian</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Greten</surname>
            <given-names>Florian</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vogl</surname>
            <given-names>Claus</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Müller</surname>
            <given-names>Mathias</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Decker</surname>
            <given-names>Thomas</given-names>
          </name>
          <email>thomas.decker@univie.ac.at</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">∗</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Max F. Perutz Laboratories, Department of Genetics, Microbiology and Immunobiology, University of Vienna, Dr. Bohr-Gasse 9/4, A1030 Vienna, Austria</aff>
      <aff id="aff2"><label>2</label>Departments of Microbiology and Medicine, Columbia University, 701 West 168<sup>th</sup> Street, New York, NY 10032, USA</aff>
      <aff id="aff3"><label>3</label>Klinikum Rechts der Isar, Technical University, Ismaninger Straße 22, 81675 Munich, Germany</aff>
      <aff id="aff4"><label>4</label>Institute of Animal Breeding and Genetics, University of Veterinary Medicine, Veterinärplatz 1, A1210 Vienna, Austria</aff>
      <author-notes>
        <corresp id="cor1"><label>∗</label>Corresponding author <email>thomas.decker@univie.ac.at</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>23</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>23</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <volume>33</volume>
      <issue>1</issue>
      <fpage>25</fpage>
      <lpage>34</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>3</day>
          <month>5</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>7</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2010 ELL &amp; Excerpta Medica.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>Transcriptional regulation of the <italic>Nos2</italic> gene encoding inducible nitric oxide synthase (iNOS) requires type I interferon (IFN-I) signaling and additional signals emanating from pattern recognition receptors. Here we showed sequential and cooperative contributions of the transcription factors ISGF3 (a complex containing STAT1, STAT2, and IRF9 subunits) and NF-κB to the transcriptional induction of the <italic>Nos2</italic> gene in macrophages infected with the intracellular bacterial pathogen <italic>Listeria monocytogenes</italic>. NF-κB preceded ISGF3 at the <italic>Nos2</italic> promoter and generated a transcriptional memory effect by depositing basal transcription factor TFIIH with the associated CDK7 kinase for serine 5 phosphorylation of the RNA polymerase II (pol II) carboxyterminal domain (CTD). Subsequent to TFIIH deposition by NF-κB, ISGF3 attracted the pol II enzyme and phosphorylation at CTD S5 occurred. Thus, STATs and NF-κB cooperate through pol II promoter recruitment and the phosphorylation of its CTD, respectively, as a prerequisite for productive elongation of iNOS mRNA.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Highlights</title>
        <p>► The ISGF3 and NF-κB complexes are essential for iNOS induction by <italic>L. monocytogenes</italic> ► NF-κB attracts TFIIH-CDK7; the IFN-I-ISGF3 signal recruits RNA pol II ► CDK7 deposition by NF-κB generates a transcriptional memory effect for ISGF3 activity ► NF-κB and ISGF3 effectuate an unconventional mode of transcriptional initiation</p>
      </abstract>
      <kwd-group>
        <kwd>MOLIMMUNO</kwd>
        <kwd>SIGNALING</kwd>
        <kwd>RNA</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>Introduction</title>
      <p>The production of nitric oxide (NO) occurs during innate immune responses to all classes of pathogens (<xref rid="bib4" ref-type="bibr">Bogdan, 2001</xref>). The molecule has direct antimicrobial activity, contributes to cell signaling, and regulates cell survival (<xref rid="bib4 bib53" ref-type="bibr">Bogdan, 2001; Zwaferink et al., 2008</xref>). Inducible nitric oxide synthase (iNOS), the enzyme encoded by the <italic>Nos2</italic> gene and responsible for NO production during infection, is synthesized de novo as a response to the recognition of microbial molecular patterns. Studies with bacterial lipopolysacharide (LPS) or with pathogen-infected murine cells showed that full transcriptional induction of <italic>Nos2</italic> and of NO production occurs only after synthesis of type I interferons (IFN-I) and signaling through the Janus kinase (JAK)-STAT pathway (<xref rid="bib4 bib13" ref-type="bibr">Bogdan, 2001; Gao et al., 1998</xref>). Type II IFN (IFN-γ), produced by natural killer (NK) and T cells, also enhances mouse <italic>Nos2</italic> induction by LPS in a manner requiring STAT1 activation by the IFN-γ receptor complex (IFNGR [<xref rid="bib28" ref-type="bibr">Meraz et al., 1996</xref>]). Together the published work suggests that IFN receptor-activated STATs cooperate with non-IFN signals in the transcriptional regulation of <italic>Nos2</italic>.</p>
      <p>Previous analyses of the murine <italic>Nos2</italic> promoter revealed an IFN response region and binding sites for NF-κB (<xref rid="bib22" ref-type="bibr">Kleinert et al., 2003</xref>). The IFN response region contains binding sites for STAT1 dimer (gamma IFN-activated site, GAS [<xref rid="bib50" ref-type="bibr">Xie et al., 1993</xref>]) and interferon regulatory factors (IRF [<xref rid="bib20 bib43" ref-type="bibr">Kamijo et al., 1994; Spink and Evans, 1997</xref>]). IFN-γ signaling leads to the formation of STAT1 homodimers and IRF1, both of which were shown to be essential for <italic>Nos2</italic> induction by IFN-γ/LPS (<xref rid="bib20 bib28" ref-type="bibr">Kamijo et al., 1994; Meraz et al., 1996</xref>). IFN-I causes formation of both STAT1 dimers and the ISGF3 complex, which comprise a STAT1/STAT2/IRF9 heterotrimer (<xref rid="bib7 bib41" ref-type="bibr">Darnell, 1997; Schindler et al., 2007</xref>). It is unclear which of these complexes contributes to iNOS regulation by IFN-I and whether IFN-I, like IFN-γ, stimulate <italic>Nos2</italic> transcription with strong dependence on IRF1 or other IRF family members.</p>
      <p>The analysis of signals received by the <italic>Nos2</italic> promoter directly from pattern recognition receptors emphasizes the role of NF-κB. Two sites for the transcription factor were identified (<xref rid="bib22 bib26 bib51" ref-type="bibr">Kleinert et al., 2003; Lowenstein et al., 1993; Xie et al., 1994</xref>). Particularly the binding element proximal to the transcription start proved essential for the activity of the transfected promoter.</p>
      <p><italic>Listeria monocytogenes</italic> is a Gram-positive bacterial pathogen replicating in the cytoplasm of mammalian host cells. It is recognized by a variety of different pattern recognition receptors including toll-like receptors and NOD-like receptors (TLR and NLR, respectively) (<xref rid="bib11 bib16" ref-type="bibr">Edelson and Unanue, 2002; Herskovits et al., 2007</xref>). In murine bone marrow-derived macrophages, a hitherto unknown cytoplasmic receptor initiates signaling to the IFN-I genes and subsequent release of IFN-I from the infected cells (<xref rid="bib44 bib46" ref-type="bibr">Stetson and Medzhitov, 2006; Stockinger et al., 2004</xref>). Exclusion of <italic>L. monocytogenes</italic> from the cytoplasm, e.g., by mutation of its major virulence factor Listeriolysin O, completely abrogates the ability to stimulate IFN-I production (<xref rid="bib45" ref-type="bibr">Stockinger et al., 2002</xref>). As with LPS, transcriptional induction of the <italic>Nos2</italic> promoter was strongly diminished when either IFN-I production or signaling were disrupted (<xref rid="bib46" ref-type="bibr">Stockinger et al., 2004</xref>). To continue this work, we now asked the question why the <italic>Nos2</italic> gene, unlike classical IFN-I-stimulated genes (ISGs) or NF-κB target genes, requires input from both STATs and signals derived directly from pattern recognition receptors for maximal transcriptional induction. Combining an examination of transcription factor and signaling requirements for transcriptional induction with an analysis of transcription factor binding to the <italic>Nos2</italic> promoter in situ, we conclude that NF-κB enhances carboxy-terminal domain (CTD) phosphorylation of RNA pol II, after recruitment of the enzyme by STATs.</p>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>Cytoplasmic and Precytoplasmic Signals Synergize in <italic>Nos2</italic> Induction</title>
        <p>As discussed above, the innate immune response to <italic>L. monocytogenes</italic> results initially from plasma membrane and endosomal pattern recognition during entry and from cytoplasmic sensing after cytoplasmic escape. The <italic>Nos2</italic> gene is paradigmatic for a large group of genes coregulated by pattern recognition receptors and IFN-I (<xref rid="bib9 bib48" ref-type="bibr">Doyle et al., 2002; Toshchakov et al., 2002</xref>). To test whether IFN-I synthesis was the only essential signal for <italic>Nos2</italic> induction derived from the cytoplasmic signaling, the two recognition phases were separated by treating macrophages with heat-killed <italic>L. monocytogenes</italic> (hkL) and with IFN-β either separately or together. Heat-killed <italic>Listeria</italic> are confined to phagosomes and cannot stimulate the cytoplasmic signal required for IFN-I production. hkL and IFN-β alone were poor inducers of iNOS mRNA synthesis (<xref rid="fig1" ref-type="fig">Figure 1</xref>). By contrast, both signals together synergized to produce the full-blown iNOS synthesis seen with viable <italic>L. monocytogenes</italic>. This result suggests that cytoplasmic signaling can indeed be recapitulated by providing IFN-I. In addition, it provides a valuable experimental tool to separate effects of non-IFN-I and IFN-I signals on the <italic>Nos2</italic> promoter and to study each independently from the other. In agreement with IFN-I synthesis preceding <italic>Nos2</italic> transcription, the kinetics of mRNA synthesis after infection with viable <italic>L. monocytogenes</italic> were delayed compared to the simultaneous treatment with hkL and IFN-β.</p>
        <p>Many genes expressed in macrophages infected with <italic>L. monocytogenes</italic> were found in a microarray experiment to display a pattern of regulation resembling that of the <italic>Nos2</italic> gene. 38 genes showing the strongest synergy effect between IFN-β alone and the additional presence of <italic>L. monocytogenes</italic>-derived signals are shown in <xref rid="app2" ref-type="sec">Figure S1</xref> available online.</p>
      </sec>
      <sec id="sec2.2">
        <title>Signals and Transcription Factors Required for iNOS Regulation by <italic>L. monocytogenes</italic></title>
        <p>To examine transcription factor requirements for transcriptional induction of the <italic>Nos2</italic> gene, we used bone marrow-derived macrophages from either wild-type or gene-targeted mice and infected them with <italic>L. monocytogenes</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>). As expected, <italic>Nos2</italic> expression required signaling through both the IFN and NF-κB pathways as deletion of either the <italic>Stat1</italic> or <italic>Rela</italic> (NF-κB p65) genes strongly suppressed iNOS mRNA induction in infected macrophages (<xref rid="fig2" ref-type="fig">Figure 2</xref>A). More refined analyses confirmed the importance of the IFN-I receptor (<italic>Ifnar1</italic><sup>−/−</sup> mice) and the NF-κB pathway (<italic>Rela</italic><sup>−/−</sup> and <italic>Ikbkb</italic> <sup>−/−</sup> mice, deficient for NF-κB p65 and the IKKβ kinase, respectively) and established the importance of the ISGF3 subunits STAT1, STAT2, and IRF9 (<xref rid="fig2" ref-type="fig">Figure 2</xref>B). The diminished <italic>Nos2</italic> expression observed upon interference with NF-kB signaling was not due to reduced IFN-I production as shown by the fact that addition of exogenous IFN-β did not rescue this effect. Use of macrophages derived from mice expressing STAT1 mutated at its S727 phosphorylation site (STAT1S727A) showed that phosphorylation of STAT1 at S727, important for full transcriptional induction of some IFN-γ-induced genes (<xref rid="bib49" ref-type="bibr">Varinou et al., 2003</xref>), was not required for <italic>Nos2</italic> expression. This contrasts with the reduced induction of <italic>Nos2</italic> by IFN-γ early after treatment in STAT1S727A-expressing macrophages (<xref rid="bib49" ref-type="bibr">Varinou et al., 2003</xref>). In further distinction from the IFN-γ response, the decrease resulting from IRF1 deficiency was marginal. Two additional members of the IRF family, IRF3 and IRF7, are active in <italic>L. monocytogenes</italic>-infected macrophages (<xref rid="bib47" ref-type="bibr">Stockinger et al., 2009</xref>). IRF7 deficiency did not affect <italic>Nos2</italic> expression. IRF3 deficiency reduced <italic>Nos2</italic> induction, but the defect could be rescued by the addition of IFN-β, suggesting that it resulted from reduced IFN-β synthesis, but not from a direct effect on the <italic>Nos2</italic> gene. The data suggest that IFN-I participate in <italic>Nos2</italic> regulation during <italic>L. monocytogenes</italic> infection by deploying the ISGF3 complex, but not the ancillary activity of IRFs. The low levels of iNOS expression seen after treatment up to 6 hr with IFN-β alone (<xref rid="fig1" ref-type="fig">Figure 1</xref>) were strongly reduced in mice unable to form ISGF3 (data not shown). Interestingly, this differs from the regulation of <italic>Nos2</italic> mRNA during the late stage of the IFN-I response, which has been shown to be independent of STAT1 (<xref rid="bib36" ref-type="bibr">Plumlee et al., 2009</xref>).</p>
        <p>A distinguishing feature of typical IFN-I-induced genes is that a deacetylation step is required for transcriptional induction, which can be inhibited with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA [<xref rid="bib31" ref-type="bibr">Nusinzon and Horvath, 2005</xref>]). Induced synthesis of <italic>Nos2</italic> mRNA was TSA sensitive, suggesting that the activity of STATs on the <italic>Nos2</italic> promoter abides by the same rules in this regard as the transcriptional activation of classical ISGs. MAP kinase pathways downstream of pattern recognition receptors (targeting ERK, JNK, and p38MAPK) were probed by pharmacological inhibition. None of the inhibitory drugs produced a significant reduction of <italic>L. monocytogenes</italic>-induced <italic>Nos2</italic> expression (data not shown). In summary, the data from <xref rid="fig1 fig2" ref-type="fig">Figures 1 and 2</xref> suggest that ISGF3 is the main signal derived from cytoplasmic signaling, recapitulated by the addition of exogeneous IFN-β, and that NF-κB is the major signal stimulated by hkL, provided by plasma membrane and/or endosomal pattern recognition receptors for <italic>Nos2</italic> induction. Our further investigations therefore concentrated on the interaction between these two pathways.</p>
      </sec>
      <sec id="sec2.3">
        <title>Binding of STATs and NF-κB to <italic>Nos2</italic> Promoter Chromatin in Macrophages Infected with <italic>L. monocytogenes</italic></title>
        <p>Association of the ISGF3 complex with <italic>Nos2</italic> chromatin was examined with antibodies against STAT1 and STAT2 for ChIP. Likewise, NF-κB binding was determined with antibodies to its p50 and p65 subunits. Amplification by polymerase chain reaction (PCR) was performed to reveal binding to the promoter-proximal region containing the essential NF-κB site as well as the more distal promoter containing the IFN response region and a second potential binding site for NF-κB (<xref rid="fig3" ref-type="fig">Figure 3</xref>A). Treating macrophages simultaneously with hkL and IFN-β stimulated binding of the ISGF3 subunits STAT1 and STAT2 with indistinguishable kinetics (<xref rid="fig3" ref-type="fig">Figure 3</xref>B). The same observation was made for the NF-κB subunits p50 and p65 with the notable exception that a reduction of constitutive p50 binding at the earliest time point after stimulation and preceding the phase of increased promoter binding was reproducibly observed. This finding is consistent with the reported negative regulation of NF-κB target genes by p50 homodimers in resting cells (<xref rid="bib52" ref-type="bibr">Zhong et al., 2002</xref>). NF-κB association was found exclusively with the promoter-proximal, essential site, whereas no evidence for binding to the distal site was obtained. As expected, STAT binding was caused by treatment with IFN-I alone, whereas NF-κB binding occurred after exposure to hkL (data not shown). No evidence for interdependent binding of the two transcription factors was obtained. Consistently, infection with viable <italic>L. monocytogenes</italic> resulted in similar kinetics of NF-κB p65 binding, but STAT1 association now required prior IFN-I synthesis and was therefore delayed by about 2 hr compared to direct stimulation with IFN-I (<xref rid="fig3" ref-type="fig">Figure 3</xref>C). Thus, during infection, binding of NF-κB precedes that of STAT1 and STAT2. The simultaneous presence of these proteins was further examined via a ChIP-re-ChIP procedure (<xref rid="fig3" ref-type="fig">Figure 3</xref>D). It confirmed that after both IFN-β treatment and infection with <italic>L. monocytogenes</italic>, STAT1 could be reprecipitated from a STAT2 ChIP with the expected difference in binding kinetics (see <xref rid="fig1" ref-type="fig">Figure 1</xref>).</p>
      </sec>
      <sec id="sec2.4">
        <title>Acetylation of Histones in Proximity to the IFN Response Region and to the Promoter-Proximal NF-κB Site</title>
        <p>Synergistic enhancement of transcriptional activation by ISGF3 and NF-κB might result from an interaction in the recruitment of histone acetylases to the <italic>Nos2</italic> promoter. Acetylation of histone H4 at the proximal and distal promoter elements was assessed. To correct for histone eviction, data were normalized to the levels of total H3. Increases of histone acetylation are often rather subtle, so we verified significance and quantified our data by using a q-PCR protocol. All experiments were repeated at least five times. Black bars represent amplification of the distal promoter and white bars amplification of the proximal promoter. This convention is maintained through all subsequent figures.</p>
        <p>Combined treatment of macrophages with IFN-I and hkL produced an increase of histone acetylation at both the proximal and distal promoter locations (<xref rid="fig4" ref-type="fig">Figure 4</xref>A). Treatment with IFN-I alone led to an increase of H4 acetylation almost exclusively at the distal IFN response region (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). Conversely, hkL treatment alone caused an increase in H4 acetylation predominantly at the proximal NF-κB element (<xref rid="fig4" ref-type="fig">Figure 4</xref>C). Our findings suggest that ISGF3 and NF-κB indeed cooperate in producing hyperacetylated <italic>Nos2</italic> promoter chromatin, but that their histone acetyl transferase (HAT)-recruiting activities show no signs of functional interdependence.</p>
      </sec>
      <sec id="sec2.5">
        <title>Recruitment of RNA Polymerase II to the <italic>Nos2</italic> Transcription Start Site</title>
        <p>Pol II can be bound to transcription start sites in a poised state (<xref rid="bib1 bib23 bib27" ref-type="bibr">Adelman et al., 2009; Koch et al., 2008; Margaritis and Holstege, 2008</xref>). Alternatively, the enzyme is recruited in response to the stimulus of gene activation (<xref rid="bib1" ref-type="bibr">Adelman et al., 2009</xref>). To determine which situation applies to the macrophage <italic>Nos2</italic> gene, we analyzed pol II association by ChIP. As shown in <xref rid="fig5" ref-type="fig">Figure 5</xref>A, infection with <italic>L. monocytogenes</italic> strongly increased pol II binding, suggesting that it occurs by regulated recruitment. Surprisingly, treatment with IFN-I alone also stimulated binding of pol II (<xref rid="fig5" ref-type="fig">Figure 5</xref>B). Association was somewhat, but not much, weaker than after the additional presence of hkL. In contrast to IFN-I, hkL alone did not stimulate pol II binding (<xref rid="fig5" ref-type="fig">Figure 5</xref>C). This result indicates (1) that the histone acetylation caused by NF-κB is not an absolute requirement for pol II binding and (2) that there is a mechanistic difference between ISGF3 and NF-κB in their mode of activating the <italic>Nos2</italic> promoter. IFN and STAT-dependent recruitment of pol II predicts that binding of TFIID and its TBP subunit displays the same requirement. <xref rid="fig5" ref-type="fig">Figures 5</xref>D and 5E indeed show that both pol II and TBP binding was completely abrogated when <italic>Stat1</italic><sup>−/−</sup>, <italic>Stat2</italic><sup>−/−</sup>, or <italic>Irf9</italic><sup>−/−</sup> macrophages were infected with <italic>L. monocytogenes</italic>.</p>
      </sec>
      <sec id="sec2.6">
        <title>Recruitment of TFIIH-CDK7 and Phosphorylation of the Pol II CTD</title>
        <p>Pol II, once stably bound to the initiation site, must be phosphorylated at its CTD to associate with proteins required for promoter clearance, capping of the mRNA, and elongation (<xref rid="bib5 bib17" ref-type="bibr">Chapman et al., 2008; Hirose and Ohkuma, 2007</xref>). Serine 5 (S5) of the CTD amino acid heptarepeat becomes phosphorylated first, followed by S2, to proceed to productive elongation. With NF-κB playing only a minor role in pol II recruitment, we wondered whether it might play a role in distinct steps of transcriptional initiation. We investigated CTD phosphorylation at S5 by using phosphospecific antibodies for ChIP. S5-phosphorylated pol II was precipitated from the <italic>Nos2</italic> initiation site only after treatment with both hkL and IFN-I, but not after treatment with IFN-I alone (<xref rid="fig6" ref-type="fig">Figure 6</xref>A). This confirms our notion that NF-κB might be involved in regulating CTD phosphorylation. CTD S5 kinase activity is associated with the general transcription factor TFIIH. TFIIH usually joins the initiation complex only after pol II binding. It is a multiprotein transcription factor containing the CTD S5 kinase CDK7 and a number of additional subunits including p62 (<xref rid="bib12" ref-type="bibr">Egly, 2001</xref>). As in the case of S5-phosphorylated pol II, CDK7 was associated with the <italic>Nos2</italic> initiation site after stimulation with hkL and IFN-I, but not after treatment with IFN-I alone (<xref rid="fig6" ref-type="fig">Figure 6</xref>B). In contrast to IFN-I, hkL treatment alone produced as much CDK7 binding as the combined IFN-I-hkL treatment (<xref rid="fig6" ref-type="fig">Figure 6</xref>C). The kinetics of CDK7 binding as induced by <italic>L. monocytogenes</italic> demonstrated association with the <italic>Nos2</italic> promoter at 2 hr postinfection (<xref rid="fig6" ref-type="fig">Figure 6</xref>D). At this time, NF-κB is associated with <italic>Nos2</italic> chromatin, but no or very little ISGF3 is present (<xref rid="fig3" ref-type="fig">Figure 3</xref>C). Binding of CDK7 as well as that of TFIIH p62 was abrogated by both NF-κB p65 and IKKβ deficiency (<xref rid="fig6" ref-type="fig">Figures 6</xref>E–6H). Together, these data confirm the hypothesis that a TFIIH complex is recruited by NF-κB, providing kinase activity for the pol II CTD at S5. Comparing the kinetics of NF-κB and TFIIH binding in the course of infection suggested that TFIIH remains bound at the promoter even after dissociation of NF-κB (Figures <xref rid="fig3" ref-type="fig">3</xref>, <xref rid="fig6" ref-type="fig">6</xref>G, and 6H; <xref rid="app2" ref-type="sec">Figure S2</xref>). We tested the possibility that NF-κB, by depositing TFIIH, primes the <italic>Nos2</italic> promoter for subsequent ISGF3 activity, thus providing a “transcriptional memory” effect. To this end, macrophages were given a 2 hr pulse of hkL treatment, a period sufficient for CDK7 recruitment (<xref rid="fig6" ref-type="fig">Figure 6</xref>D). The pulsed cells were left without further stimulation for various intervals, followed by a 4 hr treatment with either IFN-β alone, hkL alone, or a combination of IFN-β and hkL. The data show that for at least 24 hr, the level achieved by IFN-β treatment of pulsed cells exceeded the level achieved by IFN-β treatment of unpulsed cells (<xref rid="fig6" ref-type="fig">Figure 6</xref>I). This result is in agreement with the notion of a transcriptional memory or priming effect of NF-κB-recruited CDK7.</p>
      </sec>
      <sec id="sec2.7">
        <title>Pol II and CDK7 Recruitment by Interferon-Stimulated Genes or Classical NF-κB Target Genes</title>
        <p>The results obtained by studying <italic>Nos2</italic> regulation raise the question why the <italic>Nos2</italic> gene requires both ISGF3 and NF-κB to achieve elongation competence. They also predict that genes induced by either IFN-I or the NF-κB pathway alone should demonstrate promoter binding of both CDK7 and pol II after single treatment with IFN-I or hkL. This assumption was tested by analyzing pol II and CDK7 binding to the promoters of the IFN-I-induced <italic>Mx2</italic> gene or of the <italic>Nfkbia</italic> gene, which is activated by NF-κB for the production of IκBα to establish a feedback inhibition loop. The data summarized in <xref rid="fig7" ref-type="fig">Figures 7</xref>A–7D show that IFN-β treatment for 2 or 4 hr caused association of both pol II and CDK7 with the <italic>Mx2</italic> but not the <italic>Nfkbia</italic> promoter. Conversely, treatment with hkL to activate the NF-κB pathway increased association of pol II and CDK7 with the <italic>Nfkbia</italic> but not the <italic>Mx2</italic> promoter. Both stimuli provided together did not increase promoter binding beyond the level observed with single treatments. Consistent with this, transcriptional priming by the NF-κB pathway was not observed with either the <italic>Mx2</italic> or the <italic>Nfkbia</italic> gene (<xref rid="fig7" ref-type="fig">Figures 7</xref>E and 7F). The data are consistent with our notion that the establishment of elongation competence by cooperative signals is a gene-specific attribute and a major contribution to the regulation of the <italic>Nos2</italic> promoter by the transcription factors NF-κB and ISGF3.</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Discussion</title>
      <p>NO production is a hallmark of innate immune responses, but its influence on infected cells or organisms varies. For some pathogens, NO is an important clearance mechanism (<xref rid="bib4" ref-type="bibr">Bogdan, 2001</xref>). By contrast, <italic>L. monocytogenes</italic> stimulates macrophages to synthesize large quantities of NO, but appears to be relatively insensitive to its toxic effects under our experimental conditions (<xref rid="bib53" ref-type="bibr">Zwaferink et al., 2008</xref>). The main effect of NO is to promote the death of <italic>Listeria</italic>-infected macrophages. Our studies of <italic>Nos2</italic> regulation were prompted by the findings of several labs that the gene expression signature of cells infected with pathogens, or exposed to their pathogen-associated molecular patterns (PAMPs), results to a significant extent from cooperative signaling by pattern recognition and IFN-I receptors (<xref rid="bib9 bib48" ref-type="bibr">Doyle et al., 2002; Toshchakov et al., 2002</xref>). By using the <italic>Nos2</italic> gene as a well-studied example, we show that the need for cooperation between the ISGF3 complex and NF-κB arises from the inability of the former to provide CTD kinase activity and the lack of pol II recruitment by the latter. The prevalent mode of rendering a gene competent for transcription is to assemble a TFIID-TFIIB-pol II complex prior to the association with TFIIH (<xref rid="bib39" ref-type="bibr">Roeder, 1996</xref>). The combined ISGF3 and NF-κB activity at the <italic>Nos2</italic> promoter results in an unconventional transcription initiation complex assembly where TFIIH binds the promoter first to provide kinase activity for the subsequent recruitment of pol II. Three lines of evidence led us to this conclusion: (1) the kinetics of transcription factor and CDK7 binding during <italic>L. monocytogenes</italic> infection show that TFIIH-CDK7 recruitment occurs before pol II binding, (2) IFN-I alone is able to bring about the recruitment of pol II and hkL alone are able to stimulate CDK7 binding, and (3) CDK7 binding is abrogated in absence of the NF-κB pathway and TBP-pol II binding is abrogated in absence of ISGF3. CDK7 binding trails that of NF-κB by about 1 hr, suggesting that a complex forms at the promoter that is not preassembled and may require intermediate steps and partner proteins. Similarly, pol II binding occurs roughly 1 hr after the observed increase in STAT1 association. CDK7 remains associated with <italic>Nos2</italic> chromatin once NF-κB p65 leaves the promoter (best seen in <xref rid="app2" ref-type="sec">Figure S2</xref>), suggesting that the function of NF-κB is to load the promoter with CDK7-TFIIH, but not to maintain this association once it has been established.</p>
      <p>To our knowledge this is the first time this mode of initiation complex assembly is shown for a gene in the context of the cellular genome and as a result of ISGF3-NF-κB interaction, although several recent studies are in line with our findings (<xref rid="bib42" ref-type="bibr">Spilianakis et al., 2003</xref>). The most compelling evidence that TFIIH-CDK7 recruitment by NF-κB may be more widely used was provided in studies on the activation of the HIV LTR in response to TNF (<xref rid="bib21" ref-type="bibr">Kim et al., 2006</xref>). Contrasting the situation with <italic>Nos2</italic>, an initiation complex including a hyperphosphorylated RNA pol II was preassembled at the LTR, but, similar to our findings with <italic>Nos2</italic>, elongation competence required TNF and NF-κB to attract TFIIH-CDK7. The authors propose that NF-κB both associates with TFIIH and stimulates release of the inhibitory CDK8 from the mediator complex. Genes induced by LPS differ concerning the rate-limiting regulatory step for the onset of transcription, consisting either in the release of an elongation block to a paused polymerase or the pol II recruitment step (<xref rid="bib1" ref-type="bibr">Adelman et al., 2009</xref>). Whether and how NF-κB-mediated TFIIH recruitment contributes in both situations is not known. Therefore it will be of interest to determine to what extent this mechanism contributes to the large impact of the NF-κB pathway on infection-related gene expression and in how far <italic>Nos2</italic> represents a paradigm valid for the many genes synergistically induced by STATs and NF-κB. The mechanism of pol II recruitment to the many genes regulated by NF-κB in absence of ISGF3 requires further investigation and, conversely, the mode of TFIIH recruitment to ISGF3 target genes in the absence of NF-κB remains to be clarified. This may generally be determined by cooperative transcription factors bound to their target promoters and/or by differences in the preexisting chromatin structure and composition.</p>
      <p>Our studies allow some conclusions about the mechanism of ISGF3 action beyond the functional division of labor with NF-κB. At the <italic>Nos2</italic> promoter, ISGF3 stimulated binding of RNA pol II without requiring STAT1 phosphorylation at S727 or the helper function of IRF1. This differs from the STAT1 dimer, which is transcriptionally more active with its transactivating domain phosphorylated and requires IRF1 to induce the expression of <italic>Nos2</italic> and other genes in response to IFN-γ (<xref rid="bib20 bib37 bib49" ref-type="bibr">Kamijo et al., 1994; Ramsauer et al., 2007; Varinou et al., 2003</xref>). Data from our lab addressing IFN-γ induction of the <italic>Gbp2</italic> promoter showed that the STAT1 dimer alone cannot recruit RNA pol II (<xref rid="bib37" ref-type="bibr">Ramsauer et al., 2007</xref>). This allows speculation that the STAT2 transactivating domain may generally supersede the requirement for STAT1 S727 phosphorylation and the ancillary activity of IRF1. In accordance with our findings about acetylation of the <italic>Nos2</italic> promoter, STAT2-dependent transcriptional initiation via mediator and TFIID subunits correlates with the ability of the STAT2 TAD to contact the HATs GCN5 and PCAF (<xref rid="bib25 bib35" ref-type="bibr">Lau et al., 2003; Paulson et al., 2002</xref>). Histone acetylation is an important regulatory step for both NF-κB and STAT target genes (<xref rid="bib6 bib37" ref-type="bibr">Chen and Greene, 2004; Ramsauer et al., 2007</xref>). NF-κB as well as ISGF3-dependent acetylation of <italic>Nos2</italic> promoter chromatin was restricted to the nucleosomes adjacent to their binding sites. This resembles virus-induced histone acetylation at the IFN-β promoter or the promoter of the IFN-I-induced <italic>Ifi-56K</italic> gene that was similarly restricted to a region around the transcription factor binding sites and the transcription start (<xref rid="bib33" ref-type="bibr">Parekh and Maniatis, 1999</xref>).</p>
      <p>Reviewing our findings and corroborating studies in the perspective of <italic>L. monocytogenes</italic> infection or pathogen infection in general raises the question why some, but not all, ISGs are coupled to the NF-κB pathway. IFN-I synthesis during infection occurs in response to nucleic acid PAMPs in the cytoplasm, when endosomal TLRs are stimulated, or when TLRs resident at the plasma membrane travel to late endosomes in the process of pathogen uptake (<xref rid="bib19" ref-type="bibr">Kagan et al., 2008</xref>). With the notable exception of the cytoplasmic DNA receptor (<xref rid="bib44" ref-type="bibr">Stetson and Medzhitov, 2006</xref>), all PRRs stimulating IFN-I synthesis will also stimulate the NF-κB pathway, thus providing both signals necessary for <italic>Nos2</italic> induction. Vice versa, some PRRs capable of activating NF-κB are not normally coupled to IFN-I synthesis. Examples of these are TLR2, TLR5, and the NLR family receptors NOD1 and NOD2, which have been associated with IFN-I synthesis only in a limited number of cell types or under specific circumstances (<xref rid="bib3 bib32" ref-type="bibr">Barbalat et al., 2009; Pandey et al., 2009</xref>). Furthermore, a large number of stress or inflammatory signals, most notably those emanating from the TNF receptor family, provide NF-κB activity without concomitant IFN-I production and signaling (<xref rid="bib8" ref-type="bibr">Dempsey et al., 2003</xref>). We hypothesize that such receptors and their signals provide a TFIIH-dependent transcriptional memory effect for <italic>Nos2</italic> expression, independently of pathogen uptake. Vigorous iNOS expression and NO production are limited, however, to situations where a pathogen is engulfed and processed by host cells, and when PAMPs appear in the late endosome and cytoplasm. This mechanism is consistent with our results in <xref rid="fig6" ref-type="fig">Figure 6</xref> showing that the hkL-stimulated NF-κB pathway can provide the <italic>Nos</italic>2 promoter with transcriptional memory for a subsequent treatment with IFN-I. It ensures that large amounts of NO are made only when its antipathogen activity is needed inside cells. Continuing along these lines, the reason why classical ISGs do not require this prime-and-trigger mechanism may be that their products are less harmful and cells can afford to prepare for pathogen entry without running the risk of inflicting damage upon themselves (<xref rid="bib53" ref-type="bibr">Zwaferink et al., 2008</xref>). Although our study provides a mechanism for signal integration and a potential paradigm for cooperativity between the STAT and NF-κB pathways during infection, further experiments must reveal the biological impact of STAT-NF-κB convergence.</p>
    </sec>
    <sec sec-type="methods" id="sec4">
      <title>Experimental Procedures</title>
      <sec id="sec4.1">
        <title>Reagents</title>
        <p>Recombinant IFN-β was purchased from Biomedica (Nova Scotia, Canada) and added to culture medium to a final concentration of 250 U/ml. The inhibitors Trichostatin A (TSA) (WAKO Biochemicals, Osaka, Japan), SP600125 for c-JUN kinase inhibition (Sigma-Aldrich, St Louis, MO), SB203580 for p38MAPK inhibition (Sigma-Aldrich), and U0126 for MEK inhibition (Calbiochem, Nottingham, UK) were used in a final concentration of 150 nM, 25 nM, 4 nM, and 10 nM, respectively.</p>
      </sec>
      <sec id="sec4.2">
        <title>Bacteria and Infection</title>
        <p>The <italic>Listeria monocytogenes</italic> strain LO28 was cultured in brain heart infusion broth overnight at 37°C. Infection of cells at MOI 10 was performed as described (<xref rid="bib45" ref-type="bibr">Stockinger et al., 2002</xref>). Heat-killed <italic>Listeria</italic> (hkL) were generated by incubation of an overnight culture of LO28 in a waterbath at 70°C for 20 min.</p>
      </sec>
      <sec id="sec4.3">
        <title>Mice and Cells</title>
        <p>Animal experiments were discussed and approved by the University of Veterinary Medicine, Vienna, institutional ethics committee and carried out in accordance with protocols approved by the Austrian law (GZ 680 205/67-BrGt/2003). Mice (WT C57BL/6, <italic>Ifnar1</italic><sup>−/−</sup> [<xref rid="bib29" ref-type="bibr">Muller et al., 1994</xref>], <italic>Stat1</italic><sup>−/−</sup> [<xref rid="bib10" ref-type="bibr">Durbin et al., 1996</xref>], STAT1S727A [<xref rid="bib49" ref-type="bibr">Varinou et al., 2003</xref>], <italic>Stat2</italic><sup>−/−</sup> [<xref rid="bib34" ref-type="bibr">Park et al., 2000</xref>], <italic>Irf1</italic><sup>−/−</sup> [<xref rid="bib38" ref-type="bibr">Reis et al., 1994</xref>], <italic>Irf3</italic><sup>−/−</sup> [<xref rid="bib40" ref-type="bibr">Sato et al., 2000</xref>], <italic>Irf7</italic><sup>−/−</sup> [<xref rid="bib18" ref-type="bibr">Honda et al., 2005</xref>], <italic>Irf9</italic><sup>−/−</sup> [<xref rid="bib15" ref-type="bibr">Harada et al., 1996</xref>], and <italic>Ikbkb</italic><sup>Δ</sup> and <italic>Rela</italic><sup>Δ</sup> [<xref rid="bib14" ref-type="bibr">Greten et al., 2007</xref>]) were sacrificed for bone marrow between 7 and 10 weeks of age. All animals were in a C57BL/6 genetic background. The mice were housed under specific-pathogen-free conditions. Poly I:C-mediated deletion of IKKβ and NF-κB p65 in bone marrow cells was performed as described (<xref rid="bib14" ref-type="bibr">Greten et al., 2007</xref>). Bone marrow-derived macrophages (BMDM) were obtained by culture of bone marrow in L-cell-derived colony-stimulating factor 1 as described previously (<xref rid="bib2" ref-type="bibr">Baccarini et al., 1985</xref>).</p>
      </sec>
      <sec id="sec4.4">
        <title>RNA Preperation and qRT-PCR</title>
        <p>RNA preparation was performed with NucleoSpin RNA II Kit purchased from Macherey-Nagel (Düren, Germany) according to the manufacturer's protocol. Quantitative real-time PCR was performed on Mastercycler ep realplex S, purchased from Eppendorf (Vienna, Austria). Primer for iNOS mRNA expression and qRT-PCR were described previously (<xref rid="bib46" ref-type="bibr">Stockinger et al., 2004</xref>). Primer for MX2 and IκBα mRNA expression were as follows: MX2 fwd 5′-CCAGTTCCTCTCAGTCCCAAGATT-3′; MX2 rev 5′-TACTGGATGATCAAGGGAACGTGG-3′; IκBα fwd 5′-GCAATTTCTGGCTGGTGGG-3′; IκBα rev 5′-GATCCGCCAGGTGAAGGG-3′.</p>
      </sec>
      <sec id="sec4.5">
        <title>Chromatin Immunoprecipitation and Re-ChIP</title>
        <p>Chromatin immunoprecipitation (ChIPs) were performed according to the protocol described in <xref rid="bib30" ref-type="bibr">Nissen and Yamamoto (2000)</xref>. Antibodies used were described recently (anti-STAT1C [<xref rid="bib24" ref-type="bibr">Kovarik et al., 1998</xref>], anti-STAT2 [<xref rid="bib34" ref-type="bibr">Park et al., 2000</xref>]), purchased from Santa Cruz (Santa Cruz, CA) and used at a 1:20 dilution (anti-NF-κB p65, anti-NF-κB p50, anti-RNA Pol II, anti-CDK7, and anti-p62-TFIIH) purchased from Bethyl (Montogomery, TX) and used in a dilution of 1:100 (anti-pS5 CTD Pol II), purchased from Abcam (Cambridgeshire, UK) and used in a dilution of 1:100 (anti-histone 3 and anti-TBP), or purchased from Upstate and used in a dilution of 1:100 (anti-acetyl histone 4). ChIP data were normalized to input and, in case of histone acetylation, further normalized to total H3 and to the untreated sample to correct for histone eviction. In the re-ChIP experiments, the immunecomplexes were eluted by adding 10 mM DTT and incubation for 30 min at 37°C. The samples were diluted 40-fold in RIPA-buffer and reimmunoprecipitated.</p>
        <p>Primers used for PCR and q-PCR of the <italic>Nos2</italic> promoter were as follows: iNOS dis fwd 5′-CCAACTATTGAGGCCACACAC-3′; iNOS dis rev 5′-GCTTCCAATAAAGCATTCACA-3′; iNOS prox fwd 5′-GTCCCAGTTTTGAAGTGACTACG-3′; iNOS prox rev 5′-GTTGTGACCCTGGCAGCAG-3′; Mx2 prox fwd 5′-ACCCAGCCAAGGCCCCCTTA-3′; Mx2 prox rev 5′-GCAGCTGCCAGGGCTCAGAC; IκBα prox fwd 3′-GGACCCCAAACCAAAATCG-5′; IκBα prox rev 3′-TCAGGCGCGGGGAATTTCC-5′.</p>
      </sec>
      <sec id="sec4.6">
        <title>Microarray Analysis</title>
        <p>Macrophages were infected with an overnight culture of <italic>L. monocytogenes</italic> for 8 hr (MOI10) or treated 4 hr with IFN-β. RNA was extracted with Trizol and QIAGEN RNeasy Kit according to the manufacturers' protocol. 1 μg of RNA per sample was used for cDNA synthesis. cDNA syntheses and array-hybridizations were performed according to the manufacturers' protocol (Amersham-BioSciences; GE Healthcare).</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adelman</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Nechaev</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gilchrist</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Muse</surname>
              <given-names>G.W.</given-names>
            </name>
            <name>
              <surname>Chinenov</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Rogatsky</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>106</volume>
          <year>2009</year>
          <fpage>18207</fpage>
          <lpage>18212</lpage>
          <pub-id pub-id-type="pmid">19820169</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baccarini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bistoni</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lohmann Matthes</surname>
              <given-names>M.L.</given-names>
            </name>
          </person-group>
          <article-title>In vitro natural cell-mediated cytotoxicity against <italic>Candida albicans</italic>: Macrophage precursors as effector cells</article-title>
          <source>J. Immunol.</source>
          <volume>134</volume>
          <year>1985</year>
          <fpage>2658</fpage>
          <lpage>2665</lpage>
          <pub-id pub-id-type="pmid">3882833</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barbalat</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Locksley</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands</article-title>
          <source>Nat. Immunol.</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>1200</fpage>
          <lpage>1207</lpage>
          <pub-id pub-id-type="pmid">19801985</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdan</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide and the immune response</article-title>
          <source>Nat. Immunol.</source>
          <volume>2</volume>
          <year>2001</year>
          <fpage>907</fpage>
          <lpage>916</lpage>
          <pub-id pub-id-type="pmid">11577346</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chapman</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Heidemann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hintermair</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Eick</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Molecular evolution of the RNA polymerase II CTD</article-title>
          <source>Trends Genet.</source>
          <volume>24</volume>
          <year>2008</year>
          <fpage>289</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">18472177</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>W.C.</given-names>
            </name>
          </person-group>
          <article-title>Shaping the nuclear action of NF-kappaB</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>5</volume>
          <year>2004</year>
          <fpage>392</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">15122352</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darnell</surname>
              <given-names>J.E.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>STATs and gene regulation</article-title>
          <source>Science</source>
          <volume>277</volume>
          <year>1997</year>
          <fpage>1630</fpage>
          <lpage>1635</lpage>
          <pub-id pub-id-type="pmid">9287210</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dempsey</surname>
              <given-names>P.W.</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.Q.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The signaling adaptors and pathways activated by TNF superfamily</article-title>
          <source>Cytokine Growth Factor Rev.</source>
          <volume>14</volume>
          <year>2003</year>
          <fpage>193</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">12787559</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doyle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vaidya</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Dadgostar</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Dempsey</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Haberland</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Modlin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>IRF3 mediates a TLR3/TLR4-specific antiviral gene program</article-title>
          <source>Immunity</source>
          <volume>17</volume>
          <year>2002</year>
          <fpage>251</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">12354379</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durbin</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Hackenmiller</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <article-title>Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease</article-title>
          <source>Cell</source>
          <volume>84</volume>
          <year>1996</year>
          <fpage>443</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="pmid">8608598</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edelson</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>Unanue</surname>
              <given-names>E.R.</given-names>
            </name>
          </person-group>
          <article-title>MyD88-dependent but Toll-like Receptor 2-independent innate immunity to <italic>Listeria</italic>: No role for either in macrophage listericidal activity</article-title>
          <source>J. Immunol.</source>
          <volume>169</volume>
          <year>2002</year>
          <fpage>3869</fpage>
          <lpage>3875</lpage>
          <pub-id pub-id-type="pmid">12244184</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egly</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>The 14th Datta Lecture. TFIIH: From transcription to clinic</article-title>
          <source>FEBS Lett.</source>
          <volume>498</volume>
          <year>2001</year>
          <fpage>124</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="pmid">11412842</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Filla</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Fultz</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene</article-title>
          <source>J. Immunol.</source>
          <volume>161</volume>
          <year>1998</year>
          <fpage>4803</fpage>
          <lpage>4810</lpage>
          <pub-id pub-id-type="pmid">9794412</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greten</surname>
              <given-names>F.R.</given-names>
            </name>
            <name>
              <surname>Arkan</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Bollrath</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Goode</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Miething</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Goktuna</surname>
              <given-names>S.I.</given-names>
            </name>
            <name>
              <surname>Neuenhahn</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fierer</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Paxian</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta</article-title>
          <source>Cell</source>
          <volume>130</volume>
          <year>2007</year>
          <fpage>918</fpage>
          <lpage>931</lpage>
          <pub-id pub-id-type="pmid">17803913</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harada</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kashiwazaki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kitagawa</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yokochi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Takasugi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kadokawa</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta</article-title>
          <source>Genes Cells</source>
          <volume>1</volume>
          <year>1996</year>
          <fpage>995</fpage>
          <lpage>1005</lpage>
          <pub-id pub-id-type="pmid">9077462</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herskovits</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Auerbuch</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Portnoy</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system</article-title>
          <source>PLoS Pathog.</source>
          <volume>3</volume>
          <year>2007</year>
          <fpage>e51</fpage>
          <pub-id pub-id-type="pmid">17397264</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirose</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ohkuma</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression</article-title>
          <source>J. Biochem.</source>
          <volume>141</volume>
          <year>2007</year>
          <fpage>601</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="pmid">17405796</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Honda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yanai</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Negishi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Asagiri</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mizutani</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Ohba</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Takaoka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>IRF-7 is the master regulator of type-I interferon-dependent immune responses</article-title>
          <source>Nature</source>
          <volume>434</volume>
          <year>2005</year>
          <fpage>772</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="pmid">15800576</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kagan</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Horng</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Medzhitov</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta</article-title>
          <source>Nat. Immunol.</source>
          <volume>9</volume>
          <year>2008</year>
          <fpage>361</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">18297073</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamijo</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Matsuyama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bosland</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gerecitano</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Le</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>S.I.</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Requirement for transcription factor IRF-1 in NO synthase induction in macrophages</article-title>
          <source>Science</source>
          <volume>263</volume>
          <year>1994</year>
          <fpage>1612</fpage>
          <lpage>1615</lpage>
          <pub-id pub-id-type="pmid">7510419</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Bourgeois</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Tyagi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Karn</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency</article-title>
          <source>EMBO J.</source>
          <volume>25</volume>
          <year>2006</year>
          <fpage>3596</fpage>
          <lpage>3604</lpage>
          <pub-id pub-id-type="pmid">16874302</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kleinert</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Forstermann</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the expression of inducible nitric oxide synthase</article-title>
          <source>Biol. Chem.</source>
          <volume>384</volume>
          <year>2003</year>
          <fpage>1343</fpage>
          <lpage>1364</lpage>
          <pub-id pub-id-type="pmid">14669979</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koch</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Jourquin</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ferrier</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Andrau</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide RNA polymerase II: Not genes only!</article-title>
          <source>Trends Biochem. Sci.</source>
          <volume>33</volume>
          <year>2008</year>
          <fpage>265</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">18467100</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kovarik</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Stoiber</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Novy</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation</article-title>
          <source>EMBO J.</source>
          <volume>17</volume>
          <year>1998</year>
          <fpage>3660</fpage>
          <lpage>3668</lpage>
          <pub-id pub-id-type="pmid">9649436</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lau</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Nusinzon</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Burakov</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>L.P.</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Role of metazoan mediator proteins in interferon-responsive transcription</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>23</volume>
          <year>2003</year>
          <fpage>620</fpage>
          <lpage>628</lpage>
          <pub-id pub-id-type="pmid">12509459</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowenstein</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Alley</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Raval</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Snowman</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>90</volume>
          <year>1993</year>
          <fpage>9730</fpage>
          <lpage>9734</lpage>
          <pub-id pub-id-type="pmid">7692452</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Margaritis</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Holstege</surname>
              <given-names>F.C.</given-names>
            </name>
          </person-group>
          <article-title>Poised RNA polymerase II gives pause for thought</article-title>
          <source>Cell</source>
          <volume>133</volume>
          <year>2008</year>
          <fpage>581</fpage>
          <lpage>584</lpage>
          <pub-id pub-id-type="pmid">18485867</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meraz</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Sheehan</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Bach</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Rodig</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Dighe</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Greenlund</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway</article-title>
          <source>Cell</source>
          <volume>84</volume>
          <year>1996</year>
          <fpage>431</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="pmid">8608597</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Steinhoff</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Hemmi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pavlovic</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zinkernagel</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Aguet</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Functional role of type I and type II interferons in antiviral defense</article-title>
          <source>Science</source>
          <volume>264</volume>
          <year>1994</year>
          <fpage>1918</fpage>
          <lpage>1921</lpage>
          <pub-id pub-id-type="pmid">8009221</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nissen</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>K.R.</given-names>
            </name>
          </person-group>
          <article-title>The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain</article-title>
          <source>Genes Dev.</source>
          <volume>14</volume>
          <year>2000</year>
          <fpage>2314</fpage>
          <lpage>2329</lpage>
          <pub-id pub-id-type="pmid">10995388</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nusinzon</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Horvath</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation</article-title>
          <source>Sci. STKE</source>
          <volume>2005</volume>
          <year>2005</year>
          <fpage>re11</fpage>
          <pub-id pub-id-type="pmid">16091625</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pandey</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Fortune</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Coulombe</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Behr</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Fitzgerald</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Sassetti</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Kelliher</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>
          <source>PLoS Pathog.</source>
          <volume>5</volume>
          <year>2009</year>
          <fpage>e1000500</fpage>
          <pub-id pub-id-type="pmid">19578435</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parekh</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Maniatis</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter</article-title>
          <source>Mol. Cell</source>
          <volume>3</volume>
          <year>1999</year>
          <fpage>125</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">10024886</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Schindler</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Immune response in Stat2 knockout mice</article-title>
          <source>Immunity</source>
          <volume>13</volume>
          <year>2000</year>
          <fpage>795</fpage>
          <lpage>804</lpage>
          <pub-id pub-id-type="pmid">11163195</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Press</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tanese</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <article-title>IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff</article-title>
          <source>Nat. Cell Biol.</source>
          <volume>4</volume>
          <year>2002</year>
          <fpage>140</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">11802163</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plumlee</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Beg</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Shuman</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Schindler</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Interferons direct an effective innate response to <italic>Legionella pneumophila</italic> infection</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>30058</fpage>
          <lpage>30066</lpage>
          <pub-id pub-id-type="pmid">19720834</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramsauer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Farlik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zupkovitz</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Seiser</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kroger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>104</volume>
          <year>2007</year>
          <fpage>2849</fpage>
          <lpage>2854</lpage>
          <pub-id pub-id-type="pmid">17293456</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reis</surname>
              <given-names>L.F.</given-names>
            </name>
            <name>
              <surname>Ruffner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Aguet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Weissmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes</article-title>
          <source>EMBO J.</source>
          <volume>13</volume>
          <year>1994</year>
          <fpage>4798</fpage>
          <lpage>4806</lpage>
          <pub-id pub-id-type="pmid">7957048</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roeder</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>The role of general initiation factors in transcription by RNA polymerase II</article-title>
          <source>Trends Biochem. Sci.</source>
          <volume>21</volume>
          <year>1996</year>
          <fpage>327</fpage>
          <lpage>335</lpage>
          <pub-id pub-id-type="pmid">8870495</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Suemori</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hata</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Asagiri</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ogasawara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nakao</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nakaya</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Katsuki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction</article-title>
          <source>Immunity</source>
          <volume>13</volume>
          <year>2000</year>
          <fpage>539</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">11070172</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schindler</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>JAK-STAT signaling: From interferons to cytokines</article-title>
          <source>J. Biol. Chem.</source>
          <volume>282</volume>
          <year>2007</year>
          <fpage>20059</fpage>
          <lpage>20063</lpage>
          <pub-id pub-id-type="pmid">17502367</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spilianakis</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kretsovali</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Agalioti</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Makatounakis</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Thanos</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Papamatheakis</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>CIITA regulates transcription onset via Ser5-phosphorylation of RNA Pol II</article-title>
          <source>EMBO J.</source>
          <volume>22</volume>
          <year>2003</year>
          <fpage>5125</fpage>
          <lpage>5136</lpage>
          <pub-id pub-id-type="pmid">14517250</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spink</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Binding of the transcription factor interferon regulatory factor 1 to the inducible nitric oxide synthase promoter</article-title>
          <source>J. Biol. Chem.</source>
          <volume>272</volume>
          <year>1997</year>
          <fpage>24417</fpage>
          <lpage>24425</lpage>
          <pub-id pub-id-type="pmid">9305901</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stetson</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Medzhitov</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Recognition of cytosolic DNA activates an IRF3-dependent innate immune response</article-title>
          <source>Immunity</source>
          <volume>24</volume>
          <year>2006</year>
          <fpage>93</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="pmid">16413926</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stockinger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Materna</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Stoiber</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bayr</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Steinborn</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kolbe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Chakraborty</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Production of type I IFN sensitizes macrophages to cell death induced by <italic>Listeria monocytogenes</italic></article-title>
          <source>J. Immunol.</source>
          <volume>169</volume>
          <year>2002</year>
          <fpage>6522</fpage>
          <lpage>6529</lpage>
          <pub-id pub-id-type="pmid">12444163</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stockinger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reutterer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Schaljo</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Schellack</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Materna</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism</article-title>
          <source>J. Immunol.</source>
          <volume>173</volume>
          <year>2004</year>
          <fpage>7416</fpage>
          <lpage>7425</lpage>
          <pub-id pub-id-type="pmid">15585867</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stockinger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kastner</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kernbauer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pilz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Westermayer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reutterer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Soulat</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Stengl</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vogl</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Frenz</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the interferon-producing cell in mice infected with <italic>Listeria monocytogenes</italic></article-title>
          <source>PLoS Pathog.</source>
          <volume>5</volume>
          <year>2009</year>
          <fpage>e1000355</fpage>
          <pub-id pub-id-type="pmid">19325882</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toshchakov</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>B.W.</given-names>
            </name>
            <name>
              <surname>Perera</surname>
              <given-names>P.Y.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Cody</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Major</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Fenton</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>S.N.</given-names>
            </name>
          </person-group>
          <article-title>TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages</article-title>
          <source>Nat. Immunol.</source>
          <volume>3</volume>
          <year>2002</year>
          <fpage>392</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">11896392</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varinou</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ramsauer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Karaghiosoff</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kolbe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Pfeffer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity</article-title>
          <source>Immunity</source>
          <volume>19</volume>
          <year>2003</year>
          <fpage>793</fpage>
          <lpage>802</lpage>
          <pub-id pub-id-type="pmid">14670297</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>Q.W.</given-names>
            </name>
            <name>
              <surname>Whisnant</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nathan</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide</article-title>
          <source>J. Exp. Med.</source>
          <volume>177</volume>
          <year>1993</year>
          <fpage>1779</fpage>
          <lpage>1784</lpage>
          <pub-id pub-id-type="pmid">7684434</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>Q.W.</given-names>
            </name>
            <name>
              <surname>Kashiwabara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Nathan</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase</article-title>
          <source>J. Biol. Chem.</source>
          <volume>269</volume>
          <year>1994</year>
          <fpage>4705</fpage>
          <lpage>4708</lpage>
          <pub-id pub-id-type="pmid">7508926</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhong</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>May</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Jimi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1</article-title>
          <source>Mol. Cell</source>
          <volume>9</volume>
          <year>2002</year>
          <fpage>625</fpage>
          <lpage>636</lpage>
          <pub-id pub-id-type="pmid">11931769</pub-id>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zwaferink</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Stockinger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reipert</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of inducible nitric oxide synthase expression by beta interferon increases necrotic death of macrophages upon <italic>Listeria monocytogenes</italic> infection</article-title>
          <source>Infect. Immun.</source>
          <volume>76</volume>
          <year>2008</year>
          <fpage>1649</fpage>
          <lpage>1656</lpage>
          <pub-id pub-id-type="pmid">18268032</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Two Figures</title>
          </caption>
          <media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>We are grateful to M. Nakasato and T. Taniguchi for providing bone marrow from <italic>Irf9</italic>-deficient mice. We thank A. Jamieson and P. Kovarik for critical reading of our manuscript. This work was funded by the Austrian Research Foundation (FWF) through grants SFB-28 (to M.M. and T.D.) and P20522-B05 (to T.D.).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>Kinetics of iNOS Induction Determined by q-PCR</p>
        <p>(A) Exposure of bone marrow-derived macrophages to living <italic>L. monocytogenes</italic> (LL) or to cotreatment with <italic>heat-killed Listeria</italic> (hkL) and IFN-β.</p>
        <p>(B) Bone marrow-derived macrophages were treated with hkL, IFN-β, or a combination of both.</p>
        <p>Error bars represent standard deviations from triplicate samples. The experiments were repeated at least three times.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>iNOS mRNA Induction by <italic>L. monocytogenes</italic> Requires Stat1, Stat2, IRF9, and NF-κB Signaling</p>
        <p>(A) Bone marrow-derived macrophages of WT, <italic>Stat1</italic><sup>−/−</sup>, and <italic>Rela</italic><sup>−/−</sup> mice were infected with living <italic>L. monocytogenes</italic> (LL) for the times indicated. IFN-β was additionally present to compensate for potential defects in IFN-I production. iNOS mRNA expression was determined by q-PCR.</p>
        <p>(B) Bone marrow-derived macrophages with the indicated genotypes were infected with living <italic>L. monocytogenes</italic> (LL) for 6 hr or a combination of LL and IFN-β (<italic>Ikbkb</italic><sup>−/−</sup> + IFN-β; <italic>Rela</italic><sup>−/−</sup> + IFNβ; <italic>Irf3</italic><sup>−/−</sup> + IFN-β) for 4 hr. iNOS mRNA expression was determined by q-PCR.</p>
        <p>To be able to compare data between individual experiments, genotype-specific expression is shown as percent induction found in wild-type macrophages. Error bars represent standard deviations from triplicate samples. The mentioned experiments were repeated at least three times.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>Binding of STATs and NF-κB to the <italic>Nos2</italic> Promoter</p>
        <p>(A) Schematic drawing of the IFN response region and the NF-κB sites (NF-κB BS) in the <italic>Nos2</italic> promoter (<xref rid="bib22" ref-type="bibr">Kleinert et al., 2003</xref>). Binding of STATs and NF-κB to the <italic>Nos2</italic> promoter in response to signals stimulated by exposure to <italic>L. monocytogenes</italic>.</p>
        <p>(B) Bone marrow-derived macrophages were stimulated with hkL and IFN-β and the cells were processed for ChIP at the indicated time points. Antibodies used for ChIP are shown on the left, P.I. indicates controls performed with preimmune sera. The precipitates were amplified with primers flanking the proximal (NF-κB) or distal (STAT1, IRF) promoter regions as depicted in (A) and analyzed by gel electrophoresis.</p>
        <p>(C) Bone marrow-derived macrophages were infected with viable <italic>L. monocytogene</italic>s and processed as described in (B).</p>
        <p>(D) Bone marrow-derived macrophages were either treated with IFN-β or infected with living <italic>L. monocytogenes</italic> (LL) for the times indicated and processed for ChIP-Re-ChIP.</p>
        <p>Antibodies used for ChIP and Re-ChIP are shown on top of the panels. The precipitates were amplified with primers flanking the distal <italic>Nos2</italic> promoter region and analyzed by q-PCR. Error bars represent standard deviations from triplicate samples. The experiments were repeated at least three times.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Figure 4</label>
      <caption>
        <p>Histone 4 Acetylation at the <italic>Nos2</italic> Promoter</p>
        <p>Bone marrow-derived macrophages were treated with hkL and IFN-β (A), IFN-β alone (B), or hkL alone (C) as indicated. ChIP was performed with antibodies to acetyl-histone 4 (acH4) and with antibodies to histone 3 (H3). The presence of distal (black) or proximal (white) <italic>Nos2</italic> promoter fragments was determined by q-PCR. Data are expressed as increase of acH4 signals normalized to H3 signals to correct for histone eviction. The histograms thus denote the ratio of acetyl-histone 4 binding as a function of total histone 3 (acH4/H3). Error bars represent standard deviations from triplicate samples. All experiments were repeated at least five times.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Figure 5</label>
      <caption>
        <p>Recruitment of RNA Polymerase II to the <italic>Nos2</italic> Promoter by <italic>L. monocytogenes</italic>-Derived Signals</p>
        <p>Bone marrow-derived macrophages from wild-type mice (A–E) or <italic>Stat1</italic><sup>−/−</sup>, <italic>Stat2</italic><sup>−/−</sup>, and <italic>Irf9</italic><sup>−/−</sup> mice (D, E) were infected with living <italic>L. monocytogenes</italic> (LL [A, D, E]), with IFN-β alone (B), heat-killed <italic>Listeria</italic> alone (hkL [C]), or with a combination of IFN-β and hkL (B, C) for the times indicated. The cells were processed for ChIP with antibodies against pol II (A–D) or TBP (E). The precipitated DNA was analyzed by q-PCR with primers amplifying the distal (black) and proximal (white) promoter regions. Panels (D) and (E) show a comparison of proximal promoter fragments in ChIP from WT (black), <italic>Stat1</italic><sup>−/−</sup> (red), <italic>Stat2</italic><sup>−/−</sup> (yellow), and <italic>Irf9</italic><sup>−/−</sup> (green) macrophages. Error bars represent standard deviations from triplicate samples. The experiments were repeated at least three times.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>Figure 6</label>
      <caption>
        <p>TFIIH-CDK7 Recruitment to the <italic>Nos2</italic> Promoter and S5 Phosphorylation of the RNA Polymerase II CTD by <italic>L. monocytogenes</italic>-Derived Signals; Analysis of <italic>Nos2</italic> Promoter Priming by hkL</p>
        <p>(A–H) Bone marrow-derived macrophages from WT mice (A–H), <italic>Ikbkb</italic><sup>−/−</sup> mice (E, F), or <italic>Rela</italic><sup>−/−</sup> mice (G, H) were infected with living <italic>L. monocytogenes</italic> (LL [D–H]), with IFN-β alone (A, B), with hkL alone (C), or with a combination of IFN-β and hkL (A–C) for the times indicated. The cells were processed for ChIP with antibodies against S5-phosphorylated pol II (A), CDK7 (B–E, G), or the TFIIH subunit p62 (F, H). The precipitated DNA was analyzed by q-PCR with primers amplifying the distal (black) and proximal (white) promoter regions. Panels (E)–(H) show a comparison of proximal promoter fragments in ChIP from WT (black), <italic>Ikbkb</italic><sup>−/−</sup> (red, E, F), and <italic>Rela</italic><sup>−/−</sup> (orange, G, H) macrophages.</p>
        <p>(I) Bone marrow-derived macrophages were pretreated with hkL for 2 hr or left without pretreatment followed by extensive washing of the cells. The cells were then left without treatment for different periods of time (indicated as hours gap). Thereafter cells were stimulated with hkL + IFN-β, IFN-β alone, or hkL alone for 4 hr. iNOS mRNA expression was determined by q-PCR.</p>
        <p>Error bars represent standard deviations from triplicate samples. The experiments were repeated at least three times.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>Figure 7</label>
      <caption>
        <p>RNA Pol II and CDK7 Recruitment to the Proximal Promoter Regions of the IFN-Inducible <italic>Mx2</italic> Gene and the Gene Encoding IκB; Analysis of <italic>Mx2</italic> and <italic>Nfkbia</italic> Promoter Priming by hkL</p>
        <p>(A–D) Bone marrow-derived macrophages from wild-type mice were treated with hkL + IFN-β, hkL alone, or IFN-β alone for the times indicated. The cells were processed for ChIP with antibodies against pol II (A, C) or CDK7 (B, D). The precipitated DNA was analyzed by q-PCR with primers amplifying the proximal promoter regions of the <italic>Mx2</italic> gene (A, B) and the <italic>Nfkbia</italic> gene (the gene encoding IκBα) (C, D).</p>
        <p>(E and F) Bone marrow-derived macrophages were pretreated with hkL for 2 hr or left without pretreatment followed by extensive washing of the cells. The cells were then left without treatment for different periods of time (indicated as hours gap). Thereafter cells were stimulated with hkL + IFN-β, IFN-β alone, or hkL alone for 4 hr. Mx2 (E) and IκBα (F) mRNA expression was determined by q-PCR. Error bars represent standard deviations from triplicate samples. The experiments were repeated at least three times.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
  </floats-group>
</article>